摘要:
The present invention relates to novel compounds having the following formula (I), and the use thereof as a drug, particularly for the treatment of tumors associated with hyperactivation of the hedgehog protein signaling pathway, for the treatment of neurodegenerative diseases, for the treatment of diseases related to cerebral development (holoprosencephaly), for stem cell monitoring, for the treatment of cerebrovascular accidents and cardiovascular accidents, for the treatment of diseases involving oligodendrocytes and diseases involving neurolemmocytes, for application thereof in vitro for modulating human or animal stem cell renewal, and for the treatment of diabetes. The present invention also relates to pharmaceutical compositions comprising at least one compound having formula (I). The invention also relates to a method for radio-marking compounds having formula (I), the marked compounds, and the use of said compounds as research tools. Finally, the present invention also relates to a method for screening and/or identifying ligands in the Smoothened receptor (Smo) binding sites, methods for identifying agonists and antagonists of the Smoothened receptor, and a method for identifying cells.
摘要:
The present invention relates to acyl guanidine derivatives modulating the hedgehog protein signaling pathway to be used as drugs, in particular for treating diseases involving a tissue dysfunction associated with a deregulation of the hedgehog protein signaling pathway, as well as to pharmaceutical compositions containing same. The present invention also relates to novel acyl guanidine derivatives as such.